LifeVantage Presents TrueScience Skincare Regimen at IFSCC Conference

LifeVantage Corporation (Nasdaq:LFVN), announced today that Nathalie Chevreau, PhD, Senior Vice President of Research and Development, presented two abstracts describing the innovative aspects of TrueScience skin care regimen at the 2015 International Federation of Societies of Cosmetic Chemists Conference in Zurich, Switzerland.

Dr. Chevreau presented the anti-aging effect of the TrueScience skin care regimen through gene modulation in the skin layers, as well as a treatment of intrinsic and extrinsic aging.  Visible and measurable clinical outcomes can be attributed to the unique Nrf2 ingredients extensive anti-aging efficacy and reversal of cellular stress and DNA damage.

The International Federation of Societies of Cosmetic Chemists (IFSCC) is a worldwide federation dedicated to international cooperation in cosmetic science and technology.  Currently 47 Societies representing 57 countries are members. Individual membership now exceeds 15,000.

“IFSCC is the highest platform to present scientific findings in cosmetic science,” said Dr. Chevreau. “The TrueScience skin care regimen uniquely demonstrates the benefit of Nrf2 technology to protect the skin from oxidative stress. This is a fantastic invitation for LifeVantage to step onto the world stage as the leader in anti-aging skin care and cellular stress protection.”

About LifeVantage Corporation LifeVantage Corporation (Nasdaq:LFVN), is a science based network marketing company dedicated to visionary science that looks to transform health, wellness and anti-aging internally and externally at the cellular level. The company is the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, the TrueScience™ Anti-Aging Skin Care Regimen, Canine Health, and the AXIO™ energy product line.  LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.

Forward Looking StatementsThis document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe", "hopes", "intends", "estimates", "expects", "projects", "plans", "anticipates", "look forward to", “goal”, and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding our leadership in the global market, future growth and financial performance. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors", and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

Company Relations Contact:

John Genna [phone]
Vice President of Communications & 
Corporate Partnerships